View Item 

Show simple item record

Phosphorus and Calcium
dc.contributor.authorKraft, Michael D.
dc.date.accessioned2018-02-05T16:48:49Z
dc.date.available2018-02-05T16:48:49Z
dc.date.issued2015-02
dc.identifier.citationKraft, Michael D. (2015). "Phosphorus and Calcium." Nutrition in Clinical Practice 30(1): 21-33.
dc.identifier.issn0884-5336
dc.identifier.issn1941-2452
dc.identifier.urihttps://hdl.handle.net/2027.42/142245
dc.publisherWiley Periodicals, Inc.
dc.publisherSAGE Publications
dc.subject.otherparenteral nutrition
dc.subject.otherparenteral nutrition solutions
dc.subject.othercalcium
dc.subject.otherhypocalcemia
dc.subject.otherhypercalcemia
dc.subject.otherphosphorus
dc.subject.otherhypophosphatemia
dc.subject.otherhyperphosphatemia
dc.subject.othernutritional support
dc.titlePhosphorus and Calcium
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelPublic Health
dc.subject.hlbsecondlevelMedicine (General)
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.contributor.affiliationumDepartment of Pharmacy Services, University of Michigan Hospitals and Health Centers, Ann Arbor, Michigan
dc.contributor.affiliationumDepartment of Clinical, Social and Administrative Sciences, University of Michigan College of Pharmacy, Ann Arbor, Michigan
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/142245/1/ncp0021.pdf
dc.identifier.doi10.1177/0884533614565251
dc.identifier.sourceNutrition in Clinical Practice
dc.identifier.citedreferenceEscalante CP Weiser MA Finkel K. Hyperphosphatemia associated with phosphorus‐containing laxatives in a patient with chronic renal insufficiency. South Med J. 1997; 90: 240 – 242.
dc.identifier.citedreferenceMundy GR Guise TA. Hypercalcemia of malignancy. Am J Med. 1997; 103: 134 – 145.
dc.identifier.citedreferenceU.S. Food and Drug Administration. Oral sodium phosphate (OSP) products for bowel cleansing (marketed as Visicol and OsmoPrep, and oral sodium phosphate products available without a prescription). http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm103354.htm. Updated January 7, 2014. Accessed September 7, 2014.
dc.identifier.citedreferenceBlock GA Port FK. Re‐evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis. 2000; 35: 1226 – 1237.
dc.identifier.citedreferenceGoodman WG Goldin J Kuizon BD et al. Coronary‐artery calcification in young adults with end‐stage renal disease who are undergoing dialysis. N Engl J Med. 2000; 342: 1478 – 1483.
dc.identifier.citedreferenceVelentzas C Meindok H Oreopoulos DG et al. Visceral calcification and the Ca X P product. Adv Exper Med Biol. 1978; 103: 195 – 201.
dc.identifier.citedreferenceNavaneethan SD Palmer SC Craig JC Elder GJ Strippoli GFM. Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials. Am J Kidney Dis. 2009; 54: 619 – 637.
dc.identifier.citedreferenceCurran MP Robinson DM. Lanthanum carbonate: a review of its use in lowering serum phosphate in patients with end‐stage renal disease. Drugs. 2009; 69: 2329 – 2349.
dc.identifier.citedreferenceFrench S Subauste J Geraci S. Calcium abnormalities in hospitalized patients. South Med J. 2012; 105: 231 – 237.
dc.identifier.citedreferenceAnast CS Winnacker JL Forte LR et al. Impaired release of parathyroid hormone in magnesium deficiency. J Clin Endocrinol Metab. 1976; 42: 707 – 717.
dc.identifier.citedreferenceFatemi G Ryzen E Flores J et al. Effect of experimental human magnesium depletion on parathyroid hormone secretion and 1,25‐dihydroxyvitamin D metabolism. J Clin Endocrinol Metab. 1991; 73: 1067 – 1072.
dc.identifier.citedreferenceSmetzer J Cohen MR, eds. ISMP medication safety alert! [newsletter]. Vol. 2. Huntingdon Valley, PA: ISMP; October 22, 1997.
dc.identifier.citedreferenceSmetzer J Cohen MR, eds. ISMP medication safety alert! [newsletter]. Vol. 3. Huntingdon Valley, PA: ISMP; December 2, 1998.
dc.identifier.citedreferenceSmetzer J Cohen MR, eds. ISMP medication safety alert! [newsletter]. Vol. 5. Huntingdon Valley, PA: ISMP; December 13, 2000.
dc.identifier.citedreferenceSmetzer J Cohen MR, eds. ISMP medication safety alert! [newsletter]. Vol. 7. Huntingdon Valley, PA: ISMP; April 17, 2002.
dc.identifier.citedreferenceSmetzer J Cohen MR, eds. ISMP medication safety alert! [newsletter]. Vol. 2. Huntingdon Valley, PA: ISMP; May 7, 1997.
dc.identifier.citedreferenceSmetzer J Cohen MR, eds. ISMP medication safety alert! [newsletter]. Vol. 6. Huntingdon Valley, PA: ISMP; January 10, 2001.
dc.identifier.citedreferenceSmetzer J Cohen MR, eds. ISMP medication safety alert! [newsletter]. Vol. 6. Huntingdon Valley, PA: ISMP; January 24, 2001.
dc.identifier.citedreferenceJucgla A Sais G Curco N et al. Calcinosis cutis following liver transplantation: a complication of intravenous calcium administration. Br J Dermatol. 1995; 132: 275 – 278.
dc.identifier.citedreferenceSemple P Booth C. Calcium chloride; a reminder. Anaesthesia. 1996; 51: 93.
dc.identifier.citedreferenceForsythe RM Wessel CB Billiar TR Angus DC Rosengart MR. Parenteral calcium for intensive care unit patients. Cochrane Database Syst Rev 2008; 4: CD006163.
dc.identifier.citedreferenceVanden Hoek TL Morrison LJ Shuster M et al. Part 12: cardiac arrest in special situations: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2010; 122: S829 – S861.
dc.identifier.citedreferenceDavis KD Attie MF. Management of severe hypercalcemia. Crit Care Clin. 1991; 7: 175 – 190.
dc.identifier.citedreferenceAgus ZS Wasserstein A Goldfarb S. Disorders of calcium and magnesium homeostasis. Am J Med. 1982; 72: 473 – 488.
dc.identifier.citedreferenceDavidson TG. Conventional treatment of hypercalcemia of malignancy. Am J Health‐Syst Pharm. 2001; 58 ( suppl 3 ): S8 – S15.
dc.identifier.citedreferenceDeftos LJ. Hypercalcemia: mechanisms, differential diagnosis, and remedies. Postgrad Med. 1996; 100: 119 – 126.
dc.identifier.citedreferenceDeftos LJ First BP. Calcitonin as a drug. Ann Intern Med. 1989; 95: 192 – 197.
dc.identifier.citedreferenceNierman DM Mechanick JI. Biochemical response to treatment of bone hyperresorption in chronically critically ill patients. Chest. 2000; 118: 761 – 766.
dc.identifier.citedreferenceOlinger ML. Disorders of calcium and magnesium metabolism. Emerg Med Clin North Am. 1989; 7: 795 – 822.
dc.identifier.citedreferenceBushinsky DA Monk RD. Calcium. Lancet. 1998; 352 ( 9124 ): 306 – 311.
dc.identifier.citedreferenceKhanal RC Nemere I. Regulation of intestinal calcium transport. Ann Rev Nutr. 2008; 28: 179 – 96.
dc.identifier.citedreferenceWeisinger JR Bellorin‐Font E. Magnesium and phosphorous. Lancet. 1998; 352 ( 9125 ): 391 – 396.
dc.identifier.citedreferencePeppers MP Geheb M Desai T. Hypophosphatemia and hyperphosphatemia. Crit Care Clin. 1991; 7: 201 – 214.
dc.identifier.citedreferenceKnochel JP. The pathophysiology and clinical characteristics of severe hypophosphatemia. Arch Intern Med. 1977; 37: 203 – 220.
dc.identifier.citedreferenceStoff JS. Phosphate homeostasis and hypophosphatemia. Am J Med. 1982; 72: 489 – 495.
dc.identifier.citedreferenceSheldon GF Grzyb S. Phosphate depletion and repletion: relation to parenteral nutrition and oxygen transport. Ann Surg. 1975; 182: 683 – 689.
dc.identifier.citedreferenceTravis SF Sugerman HJ Ruberg RL et al. Alterations of red‐cell glycolytic intermediates and oxygen transport as a consequence of hypophosphatemia in patients receiving intravenous hyperalimentation. N Engl J Med. 1971; 283: 763 – 768.
dc.identifier.citedreferenceNewman JH Neff TA Ziporin P. Acute respiratory failure associated with hypophosphatemia. N Engl J Med. 1977; 296: 1101 – 1103.
dc.identifier.citedreferenceAubier M Murciano D Lecocguic Y et al. Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure. N Engl J Med. 1985; 313: 420 – 424.
dc.identifier.citedreferenceNational Academy of Sciences, Institute of Medicine. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. Available from: http://www.iom.edu/reports/1997/dietary‐reference‐intakes‐for‐calcium‐phosphorus‐magnesium‐vitamin‐d‐and‐fluoride.aspx. Published August 13, 1997. Accessed September 7, 2014.
dc.identifier.citedreferenceMirtallo J Canada T Johnson D et al. Safe practices for parenteral nutrition. JPEN J Parenter Enteral Nutr. 2004; 28 ( suppl ): S39 – S70.
dc.identifier.citedreferenceKraft MD Btaiche IF Sacks GS. Review of the refeeding syndrome. Nutr Clin Pract. 2005; 20: 625 – 633.
dc.identifier.citedreferenceLoven L Larsson L Nordstrom H Lennquist S. Serum phosphate and 2,3‐diphosphoglycerate in severely burned patients after phosphate supplementation. J Trauma. 1986; 26: 348 – 352.
dc.identifier.citedreferenceYang HT Yim H Cho YS et al. Change of serum phosphate level and clinical outcome of hypophosphatemia in massive burn patient. J Trauma Acute Care Surg. 2012; 73: 1298 – 1302.
dc.identifier.citedreferencePolderman KH Bloemers FW Peerdeman SM Girbes ARJ. Hypomagnesemia and hypophosphatemia at admission in patients with severe head injury. Crit Care Med. 2000; 28: 2022 – 2025.
dc.identifier.citedreferenceBuell JF Berger AC Plotkin JS Kuo PC Johnson LB. The clinical implications of hypophosphatemia following major hepatic resection or cryosurgery. Arch Surg. 1998; 133: 757 – 761.
dc.identifier.citedreferenceSilvis SE Paragas PD. Paresthesias, weakness, seizures, and hypophosphatemia in patients receiving hyperalimentation. Gastroenterology. 1972; 62: 513 – 520.
dc.identifier.citedreferenceSand DW Pastore RA. Paresthesias and hypophosphatemia occurring with parenteral alimentation. Digest Dis. 1973; 18: 709 – 713.
dc.identifier.citedreferenceWeinsier RL Krumdieck CL. Death resulting from overzealous total parenteral nutrition: the refeeding syndrome revisited. Am J Clin Nutr. 1981; 34: 393 – 399.
dc.identifier.citedreferenceYoussef HAE. Hypophosphatemic respiratory failure complicating total parenteral nutrition—an iatrogenic potentially lethal hazard. Anesthesiology. 1982; 57: 246.
dc.identifier.citedreferenceZaloga GP. Hypocalcemic crisis. Crit Care Clin. 1991; 7: 191 – 200.
dc.identifier.citedreferenceDickerson RN Alexander KH Minard G Croce MA Brown RO. Accuracy of methods to estimate ionized and “corrected” serum calcium concentrations in critically ill multiple trauma patients receiving specialized nutrition support. JPEN J Parenter Enteral Nutr. 2004; 28: 133 – 141.
dc.identifier.citedreferenceByrnes MC Huynh K Helmer SD Stevens C Dort JM Smith RS. A comparison of corrected serum calcium levels to ionized calcium levels among critically ill surgical patients. Am J Surg. 2005; 189: 310 – 314.
dc.identifier.citedreferenceVincent JL Bredas P Jankowski S et al. Correction of hypocalcaemia in the critically ill: what is the haemodynamic benefit? Intensive Care Med. 1995; 21: 838 – 841.
dc.identifier.citedreferenceDickerson RN Henry NY Miller PL Minard G Brown RO. Low serum total calcium concentration as a marker of low serum ionized calcium concentration in critically ill patients receiving specialized nutrition support. Nutr Clin Pract. 2007; 22: 323 – 328.
dc.identifier.citedreferenceMoore EW. Ionized calcium in normal serum, ultrafiltrates, and whole blood determined by ion‐exchange electrodes. J Clin Invest. 1970; 49: 318 – 334.
dc.identifier.citedreferenceWang S McDonnell EH Sedor FA Toffaletti JG. pH effects on measurements of ionized calcium and ionized magnesium in blood. Arch Pathol Lab Med. 2002; 126: 947 – 950.
dc.identifier.citedreferenceOrrell DH. Albumin as an aid to the interpretation of serum calcium. Clin Chimica Acta. 1971; 35: 483 – 489.
dc.identifier.citedreferenceDickerson RN Morgan LM Croce MA Minard G Brown RO. Dose‐dependent characteristics of intravenous calcium therapy for hypocalcemic critically ill patients receiving specialized nutritional support. Nutrition. 2007; 23: 9 – 15.
dc.identifier.citedreferenceDickerson RN Morgan LG Cauthen AD et al. Treatment of acute hypocalcemia in critically ill multiple‐trauma patients. JPEN J Parenter Enteral Nutr. 2005; 29: 436 – 441.
dc.identifier.citedreferenceDickerson RN Morgan LM Croce MA Minard G Brown RO. Treatment of moderate to severe acute hypocalcemia in critically ill trauma patients. JPEN J Parenter Enteral Nutr. 2007; 31: 228 – 233.
dc.identifier.citedreferenceGuéguen L Pointillart A. The bioavailability of dietary calcium. J Am Coll Nutr. 2000; 19: 119S – 136S.
dc.identifier.citedreferenceHarvey JA Zobitz MM Pak CYC. Dose dependency of calcium absorption: a comparison of calcium carbonate and calcium citrate. J Bone Miner Res. 1988; 3: 253 – 258.
dc.identifier.citedreferenceIto T Jensen RT. Association of long‐term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B 12, iron, and magnesium. Curr Gastroenterol Rep. 2010; 12: 448 – 457.
dc.identifier.citedreferenceHeller HJ Greer LG Haynes SD Poindexter JR Pak CYC. Pharmacokinetic and pharmacodynamics comparison of two calcium supplements in postmenopausal women. J Clin Pharmacol. 2000; 40: 1237 – 1244.
dc.identifier.citedreferenceRecker RR. Calcium absorption and achlorhydria. N Engl J Med. 1985; 313: 70 – 73.
dc.identifier.citedreferenceNational Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003; 42 ( suppl 3 ): S1 – S202.
dc.identifier.citedreferenceMoe SM Drüeke TB Block GA et al. KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of chronic kidney disease‐mineral and bone disorder (CKD‐MBD). Kidney Int. 2009; 76 ( suppl 113 ): S1 – S130.
dc.identifier.citedreferenceO’Keefe SJD Buchman AL Fishbein TM Jeejeebhoy KN Jeppesen PB Shaffer J. Short bowel syndrome and intestinal failure: consensus definitions and overview. Clin Gastroenterol Hepatol. 2006; 4: 6 – 10.
dc.identifier.citedreferenceMatarese LE. Nutrition and fluid optimization for patients with short bowel syndrome. JPEN J Parenter Enteral Nutr. 2013; 37: 161 – 170.
dc.identifier.citedreferenceBraga CBM Vannucchi H Freire CMM et al. Serum vitamins in adult patients with short bowel syndrome receiving intermittent parenteral nutrition. JPEN J Parenter Enteral Nutr. 2011; 35: 493 – 498.
dc.identifier.citedreferenceDeLuca HF. Vitamin D and the parenteral nutrition patient. Gastroenterology. 2009; 137: S79 – S91.
dc.identifier.citedreferenceSeidner DL. Parenteral nutrition‐associated metabolic bone disease. JPEN J Parenter Enteral Nutr. 2002; 26: S37 – S42.
dc.identifier.citedreferenceKirby DF Corrigan ML Speerhas RA Emery DM. Home parenteral nutrition tutorial. JPEN J Parenter Enteral Nutr. 2012; 36: 632 – 644.
dc.identifier.citedreferenceKruger PC Parsons PJ Galusha AL Morrissette M Recker RR Howard LJ. Excessive aluminum accumulation in the bones of patients on long‐term parenteral nutrition: postmortem analysis by electrothermal atomic absorption spectrometry. JPEN J Parenter Enteral Nutr. 2014; 38: 728 – 735.
dc.identifier.citedreferenceBengoa JM Sitrin MD Wood RJ Rosenberg IH. Amino acid‐induced hypercalciuria in patients on total parenteral nutrition. Am J Clin Nutr. 1983; 38: 264 – 269.
dc.identifier.citedreferenceLumpkin MM. Safety alert: hazards of precipitation associated with parenteral nutrition. Am J Hosp Pharm. 1994; 51: 1427 – 1428.
dc.identifier.citedreferenceHill SE Heldman LS Goo EDH Whippo PE Perkinson JC. Fatal microvascular pulmonary emboli from precipitation of a total nutrient admixture solution. JPEN J Parenter Enteral Nutr. 1996; 20: 81 – 87.
dc.identifier.citedreferenceGaasbeek A Meinders AE. Hypophosphatemia: an update on its etiology and treatment. Am J Med. 2005; 118: 1094 – 1101.
dc.identifier.citedreferenceBrunelli SM Goldfarb S. Hypophosphatemia: clinical consequences and management. J Am Soc Nephrol. 2007; 18: 1999 – 2003.
dc.identifier.citedreferenceFurlan AJ Hanson M Cooperman A Farmer RG. Acute areflexic paralysis: association with hyperalimentation and hypophosphatemia. Arch Neurol. 1975; 32: 706 – 707.
dc.identifier.citedreferenceBaughman FA Jr Papp JP. Wernicke’s encephalopathy with intravenous hyperalimentation: remarks on similarities between Wernicke’s encephalopathy and the phosphate depletion syndrome. Mt Sinai J Med. 1976; 43: 48 – 52.
dc.identifier.citedreferenceHayek ME Eisenberg PG. Severe hypophosphatemia following the institution of enteral feedings. Arch Surg. 1989; 124: 1325 – 1328.
dc.identifier.citedreferencePatel U Sriram K. Acute respiratory failure due to refeeding syndrome and hypophosphatemia induced by hypocaloric enteral nutrition. Nutrition. 2009; 25: 364 – 367.
dc.identifier.citedreferenceVanneste J Hage J. Acute severe hypophosphatemia mimicking Wernicke’s encephalopathy. Lancet. 1986; 1 ( 8471 ): 44.
dc.identifier.citedreferenceMattioli S Miglioli M Montagna P Lerro MF Pilotti V Gozzetti G. Wernicke’s encephalopathy during total parenteral nutrition: observation in one case. JPEN J Parenter Enteral Nutr. 1988; 12: 626 – 627.
dc.identifier.citedreferenceLiamis G Milionis HJ Elisaf M. Medication induced hypophosphatemia: a review. Q J Med. 2010; 103: 449 – 459.
dc.identifier.citedreferenceClark CL Sacks GS Dickerson RN et al. Treatment of hypophosphatemia in patients receiving specialized nutrition support using a graduated dosing scheme: results from a prospective clinical trial. Crit Care Med. 1995; 23: 1504 – 1510.
dc.identifier.citedreferenceBrown KA Dickerson RN Morgan LM et al. A new graduated dosing regimen for phosphorus replacement in patients receiving nutrition support. JPEN J Parenter Enteral Nutr. 2006; 30: 209 – 214.
dc.identifier.citedreferenceTaylor BE Huey WY Buchman TG Boyle WA Coopersmith CM. Treatment of hypophosphatemia using a protocol based on patient weight and serum phosphorus level in a surgical intensive care unit. J Am Coll Surg. 2004; 198: 198 – 204.
dc.identifier.citedreferenceLentz RD Brown DM Kjellstrand CM. Treatment of severe hypophosphatemia. Ann Intern Med. 1978; 89: 941 – 944.
dc.identifier.citedreferenceVannatta JB Whang R Papper S. Efficacy of intravenous phosphorous therapy in the severely hypophosphatemic patient. Arch Intern Med. 1981; 141: 885 – 887.
dc.identifier.citedreferenceAndress DL Vannatta JB Whang R. Treatment of refractory hypophosphatemia. South Med J. 1982; 75: 766 – 767.
dc.identifier.citedreferenceVannatta JB Andress DL Whang R et al. High‐dose intravenous phosphorus therapy for severe complicated hypophosphatemia. South Med J. 1983; 76: 1424 – 1426.
dc.identifier.citedreferenceKingston M Al‐Siba’i MB. Treatment of severe hypophosphatemia. Crit Care Med. 1985; 13: 16 – 18.
dc.identifier.citedreferenceRosen GH Boullata JI O’Rangers EA et al. Intravenous phosphate repletion regimen for critically ill patients with moderate hypophosphatemia. Crit Care Med. 1995; 23: 1204 – 1210.
dc.identifier.citedreferenceCharron T Bernard F Skrobik Y et al. Intravenous phosphate in the intensive care unit: more aggressive repletion regimens for moderate and severe hypophosphatemia. Intensive Care Med. 2003; 29: 1273 – 1278.
dc.identifier.citedreferenceBankhead R Boullata J Brantley S et al. A.S.P.E.N. enteral nutrition practice recommendations. JPEN J Parenter Enteral Nutr. 2009; 33: 122 – 167.
dc.identifier.citedreferenceMaier‐Dobersberger T Lochs H. Enteral supplementation of phosphate does not prevent hypophosphatemia during refeeding of cachectic patients. JPEN J Parenter Enteral Nutr. 1994; 18: 182 – 184.
dc.identifier.citedreferenceFrench C Bellomo R. A rapid intravenous phosphate replacement protocol for critically ill patients. Crit Care Resusc. 2004; 6: 175 – 179.
dc.identifier.citedreferenceTerlevich A Hearing SD Woltersdorf WW et al. Refeeding syndrome: effective and safe treatment with phosphates polyfusor. Aliment Pharmacol Ther. 2003; 17: 1325 – 1329.
dc.identifier.citedreferenceHankin ME Munz K Steinbeck AW. Total body water content in normal and grossly obese women. Med J Aust. 1976; 2: 533 – 537.
dc.identifier.citedreferenceWatson PE Watson ID Batt RD. Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr. 1980; 33: 27 – 39.
dc.identifier.citedreferenceSchoeller DA van Santen E Peterson DW et al. Total body water measurement in humans with 18 O and 2 H labeled water. Am J Clin Nutr. 1980; 33: 2686 – 2693.
dc.identifier.citedreferenceWebster JD Hesp R Garrow JS. The composition of excess weight in obese women estimated by body density, total body water and total body potassium. Hum Nutr Clin Nutr. 1984; 38C: 299 – 306.
dc.identifier.citedreferenceFoster GD Wadden TA Mullen JL et al. Resting energy expenditure, body composition, and excess weight in the obese. Metabolism. 1988; 37: 467 – 472.
dc.identifier.citedreferenceGadisseux P Sica DA Ward JD Becker DP. Severe hypophosphatemia after head injury. Neurosurgery. 1985; 17: 35 – 40.
dc.identifier.citedreferenceEhrenpreis ED Wieland JM Cabral J et al. Symptomatic hypocalcemia, hypomagnesemia, and hyperphosphatemia secondary to Fleet’s Phospho‐Soda colonoscopy preparation in a patient with a jejunoileal bypass. Dig Dis Sci. 1997; 42: 858 – 860.
dc.identifier.citedreferenceUllah N Yeh R Ehrinpreis M. Fatal hyperphosphatemia from a phosphosoda bowel preparation. J Clin Gastroenterol. 2002; 34: 457 – 458.
dc.identifier.citedreferenceAmerican Society of Health‐System Pharmacists. Drug shortages: oral sodium phosphate (over‐the‐counter) solution: http://www.ashp.org/menu/DrugShortages/DrugsNoLongerAvailable/Bulletin.aspx?id=549. Published June 12, 2013. Accessed September 7, 2014.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
ncp0021.pdf
Size:
210.0KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.